NCT03117517 Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome Status COMPLETED Phase EARLY_PHASE1
NCT03106870 Adding Metformin to Insulin in Controlling Pregestational and Gestational Diabetes Mellitus Status COMPLETED Phase NA
NCT03088670 Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients. Status COMPLETED Phase PHASE3
NCT03086733 Phase II Lung Metcore - Preoperative Metformin for Lung Cancer Status COMPLETED Phase PHASE2
NCT03086005 Study to Assess the Effect of Metformin Supplementation on IVF Outcome in Patients With Polycystic Ovarian Syndrome. Status COMPLETED Phase PHASE3
NCT03078725 Failure Rate of GLyburide And Metformin Among Gestational Diabetics Status WITHDRAWN Phase PHASE4
NCT03072485 Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03071705 Metformin Plus TKI Use in Patients With Non-Small Cell Lung Carcinoma Status UNKNOWN Phase NA
NCT03066830 Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin Status COMPLETED Phase PHASE3
NCT03061981 A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT03053544 Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer Status COMPLETED Phase PHASE2
NCT03034941 Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS Patients Status COMPLETED Phase PHASE4
NCT03031821 Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome Status TERMINATED Phase PHASE3
NCT03029702 Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT03029390 Effect of Berberine Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes Status UNKNOWN Phase PHASE4
NCT03018665 A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese Status UNKNOWN Phase PHASE4